Skystar Bio-Pharmaceutical Company news

   Watch this stock
Showing stories 1 - 10 of about 39   

Articles published

SKBI 4.01 +0.03 (0.75%)
price chart
Skystar Bio-Pharmaceutical Company Stock Upgraded (SKBI)
Skystar Bio-Pharmaceutical Company, through its subsidiaries, engages in the research, development, production, marketing, and sale of veterinary healthcare and medical care products in the People's Republic of China.
Related articles »  
Skystar Bio-Pharmaceutical Company (SKBI) Q3 2014 Results - Earnings Call ...
Greetings and welcome to the Skystar Bio-Pharmaceutical Unaudited Third Quarter Fiscal 2014 Results Conference Call. At this time, all participants are in a listen-only mode.
Related articles »  
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI)'s major shareholder ...
In a document that's submitted to the U.S. SEC, it was revealed that the major shareholder of Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) 3.98 -0.02 -0.50% John Gregory, an insider in focus, made purchase via broker for 38,730 shares of the ...
Insider Buying: John M. Gregory Buys 38730 Shares of Skystar Bio ...  sleekmoney
Insider Buying: John M. Gregory Buys 70800 Shares of Skystar Bio ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory purchased 70,800 shares of the stock in a transaction that occurred on Tuesday, December 23rd.
John M. Gregory Purchases 70800 Shares of Skystar Bio-Pharmaceutical ...  Intercooler
Related articles »  
Insider Buying: Skystar Bio-Pharmaceutical Company major shareholder ...
Skystar Bio-Pharmaceutical Company logo Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) major shareholder John M. Gregory bought 38,730 shares of the stock on the open market in a transaction that occurred on Monday, February 2nd.
Skystar Bio-Pharmaceutical Reports Third Quarter Fiscal Year 2014 Financial ...
XI'AN, CHINA--(Marketwired - Nov 14, 2014) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, today ...
Related articles »  
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results ...
Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results - Earnings Call Transcript. May. 16, 2014 10:12 AM ET | About: Skystar Bio - Pharmaceutical Company (SKBI) by: SA Transcripts. Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI).
Skystar Bio-Pharmaceutical to File Financial Results for First Quarter of ...  Marketwired (press release)
Related articles »  
Skystar Bio-Pharmaceutical (SKBI) Upgraded From Hold to Buy
NEW YORK (TheStreet) -- Skystar Bio-Pharmaceutical (SKBI - Get Report) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate ... The company's ...
Hal Mintz And Sabby Capital Disclose New Investments In StemCells Inc (STEM ...
Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) is another new addition to the equity portfolio of Sabby Capital. Mintz has bought approximately 858,500 shares, which gives him and Sabby Capital control over 9.99% of the total number of shares ...
Skystar to Launch Probiotic Supplement for Dairy Cows by End of Fiscal 2014
XI'AN, CHINA--(Marketwired - Aug 26, 2014) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced preparations to launch a ...
Related articles »